The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia

Risk factors for relapse and non-relapse mortality (NRM) in the first years after allogeneic hematopoietic stem cells transplant (allo-HSCT) for acute myeloid leukemia (AML) are well known, but their correlation with long-term survivorship is unclear. This study aims to evaluate factors that impact...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন

প্রধান লেখক:	Alessandro Bruno, Francesca Lorentino, Matteo G. Carrabba, Sara Mastaglio, Raffaella Greco, Sarah Marktel, Simona Piemontese, Magda Marcatti, Luca Vago, Francesca Farina, Daniela Clerici, Elisa Diral, Lorenzo Lazzari, Edoardo Campodonico, Daniele Sannipoli, Andrea Assanelli, Consuelo Corti, Massimo Bernardi, Jacopo Peccatori, Fabio Ciceri, Maria Teresa Lupo-Stanghellini
বিন্যাস:	Artigo
ভাষা:	Inglês
প্রকাশিত:	Frontiers Media S.A. 2026-05-01
মালা:	Frontiers in Immunology
বিষয়গুলি:	allogeneic stem cell transplantation (allo-SCT) AML - acute myeloid leukemia disease status at transplantation long term survivorship overall survival
অনলাইন ব্যবহার করুন:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1818603/full
ট্যাগগুলো:	ট্যাগ যুক্ত করুন কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!